Stock Details
LLY is Eli Lilly and Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 332.69$. Average daily volumn in 3 months 3.21M. Market cap 324.38B

Stock symbol : LLY. Exchange : NYSE. Currency : USD
Lastest price : 340.61$. Total volume : 1.68M. Market state POST
Click reload if you want to check the lastest price on market!!!

Eli Lilly and Company (LLY)
Last Price

Previous Close335.87
Day Range336.07-341.31
Bid0.00 x 1k
Ask0.00 x 1.1k
Average Volume3.21M
Market Cap324.38B
52 Week Range276.83-375.25
Trailing P/E49.22
Foward P/E29.09
Dividend (Yield %)1.35%
Ex-Dividend Date2023-02-14

Financial Details

According to Eli Lilly and Company's financial reports the company's revenue in 2022 were 28.54B an increase(0%) over the years 2021 revenue that were of 28.32B. In 2022 the company's total earnings were 6.24B while total earnings in 2021 were 5.58B( +20%).

Loading ...


Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramz... a for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.


Market Cap:
Total Assets:
Total Cash:

News about "Eli Lilly and Company"

A Eli Lilly and Company (NYSE:LLY) insider increased their holdings by 1.4% last year

Source from : YAHOO!Finance - 1 days ago

From what we can see, insiders were net buyers in Eli Lilly and Company's ( NYSE:LLY ) during the past 12 months.See details»


Eli Lilly & Co. stock rises Tuesday, outperforms market

Source from : MarketWatch - 2 days ago

Eli Lilly & Co. closed $46.79 short of its 52-week high ($384.44), which the company achieved on January 24th. The stock outperformed some of its competitors Tuesday, as Johnson & Johnson JNJ fell ...See details»

Eli Lilly And Co

Source from : Reuters - 1 days ago

following move by Eli Lilly, article with image March 14, 2023 Worldcategory Economists warn of costs if Medicare covers new obesity drugs, article with image March 11, 2023 Future of ...See details»

Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know

Source from : MSN - 23 days ago

Eli Lilly (LLY) is one of the stocks most watched ... Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead ...See details»

Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock

Source from : Nasdaq - 9 days ago

Eli Lilly (LLY) has recently been on ... Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate ...See details»

Eli Lilly Says It Will Cut the Price of Insulin

Source from : The New York Times - 29 days ago

Anyone can read what you share. By Rebecca Robbins The drugmaker Eli Lilly and Company said on Wednesday that it would significantly reduce the sticker prices of several of its lifesaving insulin ...See details»

Eli Lilly to cut insulin prices up to 70% amid federal pressure to lower costs

Source from : USA Today - 23 days ago

Eli Lilly and Co. said it will cut prices of its ... prices by 70% for the fast-acting injectable Humalog, which is the company's most commonly prescribed insulin. Lilly also will discount ...See details»

Eli Lilly and Company

Source from : Entrepreneur - 29 days ago

Eli Lilly and Company, one of three companies in the U.S. that produce insulin, said it would slash the price of its insulin products after years of calls for it to do so. We'll be in your inbox ...See details»

Drugmaker Eli Lilly capping insulin costs at $35, Biden praises action

Source from : The Telegraph - 29 days ago

Eli Lilly and Company announced Wednesday they are cutting insulin costs by 70%, capping prices at $35. IMAGE: Medical bottles and syringe are seen with Eli Lilly and Company logo displayed on a ...See details»

Eli Lilly and Company (LLY) Presents at Cowen's 43rd Annual Health Care Conference (Transcript)

Source from : Seeking Alpha - 23 days ago

[Call Starts Abruptly] at the Cowen Conference again this year. Representing the company is Mike Mason, who is President of Lilly Diabetes. So Mike, thank you for making the journey. Lots to cover ...See details»

Eli Lilly to cut insulin prices by 70%, cap monthly costs at $35

Source from : CBS News - 29 days ago

Eli Lilly plans to cut prices on its most commonly prescribed insulin products by 70% and will also cap customers' out-of-pocket costs at $35 a month for those with commercial insurance who use ...See details»


Eli Lilly cannot exclude DEI proposal requested by shareholders from proxy statement, SEC says

Source from : HR Dive - 15 days ago

The request โ€œtranscends ordinary business matters because it raises human capital management issues with a broad societal impact,โ€ the SEC said.See details»

Eli Lilly drops price of insulin 70% and expands monthly cap on out-of-pocket cost

Source from : The Indianapolis Star - 29 days ago

Eli Lilly and Co., announced Wednesday that it will reduce the price of insulin and cap the monthly cost to most of its insulin users at $35 starting in May, putting the life saving drug within ...See details»

Eli Lilly to cap monthly insulin cost at $35, slash some prices by 70%

Source from : - 29 days ago

INDIANAPOLIS -- Eli Lilly and Company announced Wednesday it will expand a program that caps monthly out-of-pocket costs for patients using insulin at $35 or less and cut the price of its most ...See details»